Chemelot Ventures was established in 2014 as a Dutch limited liability company.
Limited partners of the fund are DSM Nederland, NV LIOF, Limburg Province and Rabobank, each with a commitment of € 10 million. The fund’s life is 12 years with an investment period of six years during which it aims to invest in up to 20 companies.
Chemelot Ventures focuses on sustainable chemicals & materials, regenerative medicine & biomedical materials and diagnostics & analytics, and invests in companies with product as well as process innovations.
For an overview of Chemelot Ventures’ active portfolio companies click here.